Naloxone gel - Mucodel

Drug Profile

Naloxone gel - Mucodel

Alternative Names: Exonal; Naloxone buccal gel - Mucodel; Naloxone intranasal gel - Mucodel

Latest Information Update: 16 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Mucodel
  • Class Antidotes; Morphinans; Small molecules
  • Mechanism of Action Opioid receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Opioid abuse

Most Recent Events

  • 11 Dec 2017 Mucodel completes a pilot clinical trial in Opioid abuse in USA (Intranasal)
  • 15 Mar 2017 Mucodel Pharma receives patent allowance for its naloxone buccal gel in USA
  • 21 Sep 2016 Phase-I clinical trials in Opioid abuse in USA before Sep 2016 (Buccal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top